cbdMD (YCBD)
(Delayed Data from AMEX)
$0.59 USD
+0.01 (2.08%)
Updated Jul 15, 2024 03:55 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for cbdMD, Inc falls in the month of September.
All items in Millions except Per Share data.
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 2 | 8 | 27 | 15 | 6 |
Receivables | 1 | 1 | 1 | 1 | 3 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 4 | 4 | 5 | 5 | 4 |
Other Current Assets | 1 | 3 | 3 | 3 | 3 |
Total Current Assets | 8 | 16 | 37 | 24 | 16 |
Net Property & Equipment | 1 | 1 | 3 | 3 | 2 |
Investments & Advances | 1 | 2 | 1 | 1 | 1 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 3 | 18 | 80 | 76 | 76 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 16 | 41 | 125 | 111 | 95 |
Liabilities & Shareholders Equity | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 2 | 3 | 3 | 3 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 1 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 1 | 2 | 3 | 3 | 1 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 5 | 5 | 7 | 8 | 4 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 1 | 2 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 1 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 10 | 16 | 51 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 7 | 9 | 22 | 32 | 57 |
Shareholders Equity | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 183 | 179 | 176 | 127 | 97 |
Retained Earnings | -174 | -147 | -73 | -47 | -60 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 9 | 31 | 103 | 79 | 38 |
Total Liabilities & Shareholder's Equity | 16 | 41 | 125 | 111 | 95 |
Total Common Equity | 9 | 31 | 103 | 79 | 38 |
Shares Outstanding | 2.80 | 1.30 | 1.20 | 1.10 | 0.60 |
Book Value Per Share | 3.22 | 24.16 | 85.94 | 71.98 | 62.67 |
Fiscal Year End for cbdMD, Inc falls in the month of September.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 2 | 2 | 2 | 3 |
Receivables | NA | 1 | 1 | 1 | 1 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 3 | 4 | 4 | 4 |
Other Current Assets | NA | 1 | 1 | 1 | 2 |
Total Current Assets | NA | 7 | 7 | 8 | 10 |
Net Property & Equipment | NA | 1 | 1 | 1 | 1 |
Investments & Advances | NA | 1 | 1 | 1 | 2 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 3 | 3 | 3 | 17 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 15 | 15 | 16 | 33 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 1 | 2 | 2 | 1 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 4 | 3 | 1 | 2 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 7 | 6 | 5 | 4 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 3 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 11 | 8 | 7 | 7 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 183 | 183 | 183 | 183 |
Retained Earnings | NA | -180 | -176 | -174 | -157 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 3 | 7 | 9 | 26 |
Total Liabilities & Shareholder's Equity | NA | 15 | 15 | 16 | 33 |
Total Common Equity | 0 | 3 | 7 | 9 | 26 |
Shares Outstanding | 3.80 | 3.00 | 3.00 | 2.80 | 2.80 |
Book Value Per Share | 0.00 | 1.03 | 2.34 | 3.22 | 9.19 |